Daiichi Sankyo
Pia Guinto LoPresti, PhD, currently serves as the Director of Global Oncology Medical Affairs - Scientific Engagement at Daiichi Sankyo, Inc. since October 2020, following a role as Associate Director in the same department. Prior experience includes positions as VP, Medical Director at VMLY&R and Sudler & Hennessey, where expertise in IMPRINT Science was developed from June 2011 to September 2020. Pia began a post-doctoral career as Analytical Biochemist at BD and Post-Doctoral Associate at Albert Einstein College of Medicine, focusing on cardiac regulatory proteins. Early experience featured research internships at Johnson & Johnson and St. Joseph's Hospital. Education includes a PhD and Master of Science in Physiology and Biophysics from Albert Einstein College of Medicine and a Bachelor of Science in Biological Sciences from Cook College, Rutgers University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.